Publication: Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD
No Thumbnail Available
Identifiers
Date
2018-01-01
Authors
Alcazar-Navarrete, Bernardino
Ruiz Rodriguez, Oliverio
Conde Baena, Pablo
Romero Palacios, Pedro Jose
Agusti, Alvar
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
European respiratory soc journals ltd
Metrics
Export
Abstract
Preventing the occurrence of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is a major therapeutic goal. We hypothesise that persistently increased levels of exhaled nitric oxide (FeNO) during follow-up can identify a group of COPD patients at higher risk of AECOPD.To test this hypothesis, we measured FeNO levels (HypAir FeNO (R), Medisoft; Sorinnes, Belgium) prospectively in 226 clinically stable COPD outpatients at recruitment and during follow-up (at 6 and 12 months). Patients were stratified according to the number of visits with FeNO >= 20 ppb.FeNO was = 20 ppb.FeNO was = 20 ppb in clinically stable COPD outpatients are associated with a significantly higher risk of AECOPD.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Obstructive pulmonary-disease, Eosinophilic airway inflammation, Blood eosinophils, Overlap syndrome, Asthma, Mortality, Life